Send a comment on this item to LII:
Send a comment on this item to LII staff, who on weekdays will usually reply within 24 hours.
Food and Drug Administration: Decision Process to Deny Initial Application for Over-the-Counter Marketing of the Emergency Contraceptive Drug Plan B Was Unusual
November 2005 Government Accountability Office (GAO) report about unusual aspects in the decision-making process that resulted in the FDA's 2004 decision against letting the morning-after birth control pill (also known as "Plan B") be sold without a prescription. Includes highlights from the report and the full report.
http://www.gao.gov/products/GAO-06-109
Asterisk
*
indicates required field.
Your Name
Your Email Address
*
We will not sell or provide your email address to anyone else.
Comment
*
Enter the verification code as it is shown in the box below. This helps prevent automated submissions.
*
